glycoside/비만증

This invention relates to a family of fluorinated C-aryl glycoside compounds, the process for their preparation, as well as the application of same in the pharmaceutical and cosmetics fields, in particular for the treatment of diabetes and obesity. Sugars and the derivatives thereof constitute one

TECHNICAL FIELD The present invention relates to a method for producing a C-glycoside derivative which is useful as a Na.sup.+-glucose cotransporter inhibitor for treating and preventing, in particular, diabetes such as insulin-dependent diabetes (type 1 diabetes), non-insulin-dependent diabetes

FIELD OF THE INVENTION The present invention relates generally to methods and compositions for modulating the body weight of mammals including animals and humans, and more particularly to materials identified herein as modulators of weight, and the use of these materials for treating obesity and

FIELD OF THE INVENTION Background of the Invention Obesity, which is defined in general terms as an excess of body fat relative to lean body mass, is now a world wide epidemic, and is one of the most serious contributors to increased morbidity and mortality. Obesity is prevalent in the United

BACKGROUND OF THE INVENTION Carbohydrates are eaten either as simple sugars or as more complex molecules called polysaccharides, which are built up from simple sugar units and of which the starch of potatoes, bread, etc., is a well-known example. The body absorbs carbohydrates from the small

BACKGROUND OF THE INVENTION Carbohydrates are eaten either as simple sugars or as more complex molecules called polysaccharides, which are built up from simple sugar units and of which the starch of potatoes, bread, etc., is a well-known example. The body absorbs carbohydrates from the small

CROSS REFERENCE TO RELATED APPLICATIONS This application is a national phase application of International Application Number PCT/JP2004/003324, filed Mar. 12, 2004, and claims the priority of Japanese Patent Application No. 2003-070297, filed Mar. 14, 2003, the content of both of which is

FIELD OF THE INVENTION The present invention relates to C-glycoside derivatives and salts thereof. More particularly, the present invention relates to C-glycoside derivatives and salts thereof useful as a Na+-glucose cotransporter inhibitor. C-glycoside derivatives and salts thereof of the present

BACKGROUND TO THE INVENTION 1. Field of the Invention This invention relates to Caralluma extract, and, more particularly, this invention relates to a treatment and management of obesity and obesity-related symptoms/problems/disorders and other disorders using the Caralluma extracts, to pregnane

TECHNICAL FIELD The present invention relates to compositions comprising one or more anthraquinones for use in the treatment of obesity, metabolic disease, or liver disease. More particularly it relates to a plant extract fraction rich in anthraquinones including both anthraquinone glycosides (major

TECHNICAL FIELD The present invention relates to compositions comprising one or more anthraquinones for use in the treatment of obesity, metabolic disease, or liver disease. More particularly it relates to a plant extract fraction rich in anthraquinones including both anthraquinone glycosides (major

BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to the treatment of insulin related diseases, obesity, diabetes mellitus, hyperglycemia, lipid disorders, hyperlipidemia, or low HDL, hypercholesterolemia, hyperglyceridemia, dyslipidemia, and atherosclerosis. The

BACKGROUND OF THE INVENTION It is known that in animals and man, after the intake of starchy foodstuffs and beverages, hyperglycaemias arise which are caused by a rapid splitting of the starch by amylases of the digestive tract according to the following equation: These hyperglycaemias are